There wasn’t much working in favor of sustainable investing strategies in the second quarter of 2022, as many of the major ESG tech stocks faced huge depreciations. While energy stocks continued their strong run, sustainable investing strategies seemed to lag overall.
That's where healthcare stocks come in. Sought out as a safe haven from the market turmoil, the strong returns of stocks like Gilead Sciences (GILD) and Bristol-Myers Squibb (BMY) were ultimately essential to the buoyancy of many ESG strategies.